Skip to content
Talk Evidence - cloning, reporting, and disseminating episode artwork

May 5, 2023 47 min

Talk Evidence - cloning, reporting, and disseminating

from Talk Evidence Hosted by The BMJ

Helen Macdonald, Juan Franco, and Joe Ross are back with our monthly update on the world of evidence based medicine. This episode delves into new methodologies which can use observational data to emulate trial data. We discuss a new systematic review and meta-analysis of RCTs for surgical treatment of sciatica. There is elaboration and explanation of the CONSORT Harms 2022 statement - and we'll be asking if it goes far enough. Finally, the old chestnut of surrogate endpoints in cancer treatment trials - are benefits communicated to patients accurately? Reading list; Nirmatrelvir and risk of hospital admission or death in adults with covid-19: emulation of a randomized target trial using electronic health records - https://www.bmj.com/content/381/bmj-2022-073312 Surgical versus non-surgical treatment for sciatica https://www.bmj.com/content/381/bmj-2022-070730 CONSORT Harms 2022 statement, explanation, and elaboration https://www.bmj.com/content/381/bmj-2022-073725 Funders crack down on unpublished clinical trials—but is it enough? https://www.bmj.com/content/381/bmj.p840 Communication of anticancer drug benefits and related uncertainties to patients and clinicians https://www.bmj.com/content/380/bmj-2022-073711

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Talk Evidence - cloning, reporting, and disseminating

0:00 47:02

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Talk Evidence?

This episode is 47 minutes long.

When was this Talk Evidence episode published?

This episode was published on May 5, 2023.

Can I download this Talk Evidence episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.